Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,241.86
2,839.21
2,419.41
2,047.50
1,846.08
1,842.33
1,686.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,241.86
2,839.21
2,419.41
2,047.50
1,846.08
1,842.33
1,686.38
Raw Material Cost
736.83
623.49
577.07
546.46
532.45
586.47
412.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.90
12.67
17.34
15.97
15.34
29.31
23.46
Selling and Distribution Expenses
911.76
938.73
901.13
842.96
756.18
732.61
672.21
Other Expenses
69.01
73.45
72.94
63.36
61.35
59.88
69.15
Total Expenditure (Excl Depreciation)
2,349.56
2,309.40
2,224.97
2,039.03
1,917.42
1,947.20
1,800.18
Operating Profit (PBDIT) excl Other Income
892.3000000000001
529.8
194.4
8.5
-71.3
-104.9
-113.80000000000001
Other Income
63.29
86.49
32.16
160.61
20.87
96.43
68.33
Operating Profit (PBDIT)
1,035.15
712.72
330.99
271.04
57.57
97.44
59.82
Interest
10.90
12.67
17.34
15.97
15.34
29.31
23.46
Exceptional Items
-462.22
-61.86
-20.71
-3.53
-9.55
-4.57
-25.87
Gross Profit (PBDT)
2,505.04
2,215.72
1,842.35
1,501.04
1,313.63
1,255.86
1,273.41
Depreciation
79.56
96.43
104.39
101.97
108.04
105.88
105.30
Profit Before Tax
482.48
541.76
188.56
149.58
-75.35
-42.32
-94.81
Tax
133.58
114.90
20.92
8.02
-11.27
-901.42
-70.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
348.90
426.86
167.65
141.56
-64.08
859.10
-23.85
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
348.90
426.86
167.65
141.56
-64.08
859.10
-23.85
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
348.90
426.86
167.65
141.56
-64.08
859.10
-23.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,087.00
5,657.99
4,951.55
4,603.16
4,270.74
4,106.00
3,122.38
Earnings per share (EPS)
1.8
2.21
0.88
0.75
-0.35
4.53
-0.13
Diluted Earnings per share
1.8
2.21
0.88
0.75
-0.35
4.53
-0.13
Operating Profit Margin (Excl OI)
27.52%
18.66%
8.04%
0.41%
-3.86%
-5.69%
-6.75%
Gross Profit Margin
17.34%
22.48%
12.11%
12.29%
1.77%
3.45%
0.62%
PAT Margin
10.76%
15.03%
6.93%
6.91%
-3.47%
46.63%
-1.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 14.18% vs 17.35% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -18.27% vs 154.71% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 55.21% vs 109.57% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -14.17% vs -26.59% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of BioMarin Pharmaceutical, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
3,241.86
4,338.00
-1,096.14
-25.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,241.86
4,338.00
-1,096.14
-25.27%
Raw Material Cost
736.83
1,445.00
-708.17
-49.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.90
101.00
-90.10
-89.21%
Selling and Distribution Expenses
911.76
1,078.00
-166.24
-15.42%
Other Expenses
69.01
85.00
-15.99
-18.81%
Total Expenditure (Excl Depreciation)
2,349.56
3,474.00
-1,124.44
-32.37%
Operating Profit (PBDIT) excl Other Income
892.30
864.00
28.30
3.28%
Other Income
63.29
33.00
30.29
91.79%
Operating Profit (PBDIT)
1,035.15
1,167.00
-131.85
-11.30%
Interest
10.90
101.00
-90.10
-89.21%
Exceptional Items
-462.22
290.00
-752.22
-259.39%
Gross Profit (PBDT)
2,505.04
2,893.00
-387.96
-13.41%
Depreciation
79.56
270.00
-190.44
-70.53%
Profit Before Tax
482.48
1,086.00
-603.52
-55.57%
Tax
133.58
236.00
-102.42
-43.40%
Provisions and contingencies
0
0
0.00
Profit After Tax
348.90
850.00
-501.10
-58.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
348.90
850.00
-501.10
-58.95%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
348.90
850.00
-501.10
-58.95%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,087.00
2,723.00
3,364.00
123.54%
Earnings per share (EPS)
1.80
5.45
-3.65
-66.97%
Diluted Earnings per share
1.80
5.45
-3.65
-66.97%
Operating Profit Margin (Excl OI)
27.52%
19.92%
0.00
7.60%
Gross Profit Margin
17.34%
31.26%
0.00
-13.92%
PAT Margin
10.76%
19.59%
0.00
-8.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 324.19 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 14.18% vs 17.35% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 34.89 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -18.27% vs 154.71% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 97.19 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 55.21% vs 109.57% in Dec 2024
Annual - Interest
Interest 1.09 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -14.17% vs -26.59% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.52%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
